Gyre Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024
Period EndingDec 2024
Valuation Ratios
Enterprise Value Ratios
Profitability & Returns
Return on Capital Employed (ROCE)-2.64%
Leverage & Solvency Ratios
Debt/Equity-3.27
Liquidity Ratios
Current Ratio3.62
Quick Ratio3.62
Efficiency Ratios
Yield & Distribution Ratios